103 related articles for article (PubMed ID: 21510802)
21. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
[TBL] [Abstract][Full Text] [Related]
22. The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.
Wescombe L; Lahooti H; Gopinath B; Wall JR
Clin Endocrinol (Oxf); 2010 Oct; 73(4):522-8. PubMed ID: 20039900
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
24. Proteomics Screening of Differentially Expressed Cytokines in Tears of Patients with Graves' Ophthalmopathy.
Song RH; Wang B; Yao QM; Li Q; Jia X; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2020; 20(1):87-95. PubMed ID: 31237218
[TBL] [Abstract][Full Text] [Related]
25. Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells.
Brandau S; Bruderek K; Hestermann K; Görtz GE; Horstmann M; Mattheis S; Lang S; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6549-57. PubMed ID: 26457540
[TBL] [Abstract][Full Text] [Related]
26. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
[TBL] [Abstract][Full Text] [Related]
27. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy.
Yoon JS; Chae MK; Lee SY; Lee EJ
Br J Ophthalmol; 2012 Aug; 96(8):1117-21. PubMed ID: 22661653
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis and differentiation capacity of adipose-derived stem cells from lymphedema tissue.
Levi B; Glotzbach JP; Sorkin M; Hyun J; Januszyk M; Wan DC; Li S; Nelson ER; Longaker MT; Gurtner GC
Plast Reconstr Surg; 2013 Sep; 132(3):580-589. PubMed ID: 23985633
[TBL] [Abstract][Full Text] [Related]
32. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.
Kumar S; Bahn RS
J Clin Endocrinol Metab; 2003 Sep; 88(9):4246-50. PubMed ID: 12970294
[TBL] [Abstract][Full Text] [Related]
33. Lipidomic differentiation of Graves' ophthalmopathy in plasma and urine from Graves' disease patients.
Byeon SK; Park SH; Lee JC; Hwang S; Ku CR; Shin DY; Yoon JS; Lee EJ; Moon MH
Anal Bioanal Chem; 2018 Nov; 410(27):7121-7133. PubMed ID: 30135996
[TBL] [Abstract][Full Text] [Related]
34. A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbit.
Meyer zu Hörste M; Ströher E; Berchner-Pfannschmidt U; Schmitz-Spanke S; Pink M; Göthert JR; Fischer JW; Gulbins E; Eckstein AK
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1727-36. PubMed ID: 21917865
[TBL] [Abstract][Full Text] [Related]
35. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
[TBL] [Abstract][Full Text] [Related]
37. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.
De Bellis A; Di Martino S; Fiordelisi F; Muccitelli VI; Sinisi AA; Abbate GF; Gargano D; Bellastella A; Bizzarro A
J Clin Endocrinol Metab; 1998 Apr; 83(4):1222-5. PubMed ID: 9543145
[TBL] [Abstract][Full Text] [Related]
38. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.
Ujhelyi B; Gogolak P; Erdei A; Nagy V; Balazs E; Rajnavolgyi E; Berta A; Nagy EV
Thyroid; 2012 Apr; 22(4):407-14. PubMed ID: 22385289
[TBL] [Abstract][Full Text] [Related]
39. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
40. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
